Literature DB >> 19479662

MicroRNA and stem cell regulation.

Yulei Wang1, Iain Russell, Caifu Chen.   

Abstract

Stem cells and microRNAs (miRNAs) represent two fast-developing frontiers of biological research. Stem cells function in embryonic development and tissue maintenance and are characterized by two fundamental properties: self-renewal and multipotency. Within many types of cancers, a small population of cells possesses stem cell-like characteristics. These cancer stem cells (CSCs) have been hypothesized to represent the disease-propagating and drug-resisting cell population. An increased understanding of the biology of stem cells and CSCs offers potential in the development of regenerative medicine and treatments for oncological disease. miRNAs are emerging as important regulators of post-transcriptional gene regulation, and have been demonstrated to be an integral component in stem cell regulation. This article reviews recent advances in the understanding of the roles of miRNAs in regulating various stem cell types, including embryonic stem cells, adult stem cells and CSCs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19479662

Source DB:  PubMed          Journal:  Curr Opin Mol Ther        ISSN: 1464-8431


  19 in total

Review 1.  Implication of microRNAs in drug resistance for designing novel cancer therapy.

Authors:  Fazlul H Sarkar; Yiwei Li; Zhiwei Wang; Dejuan Kong; Shadan Ali
Journal:  Drug Resist Updat       Date:  2010-03-17       Impact factor: 18.500

Review 2.  Regulating miRNA by natural agents as a new strategy for cancer treatment.

Authors:  Sajiv Sethi; Yiwei Li; Fazlul H Sarkar
Journal:  Curr Drug Targets       Date:  2013-09       Impact factor: 3.465

3.  The pro-apoptotic protein Bim is a microRNA target in kidney progenitors.

Authors:  Jacqueline Ho; Priyanka Pandey; Tobias Schatton; Sunder Sims-Lucas; Myda Khalid; Markus H Frank; Sunny Hartwig; Jordan A Kreidberg
Journal:  J Am Soc Nephrol       Date:  2011-05-05       Impact factor: 10.121

4.  Paradoxical microRNAs: individual gene repressors, global translation enhancers.

Authors:  Subramanya Srikantan; Bernard S Marasa; Kevin G Becker; Myriam Gorospe; Kotb Abdelmohsen
Journal:  Cell Cycle       Date:  2011-03-01       Impact factor: 4.534

5.  Circulating microRNA is a biomarker of pediatric Crohn disease.

Authors:  Adam M Zahm; Meena Thayu; Nicholas J Hand; Amber Horner; Mary B Leonard; Joshua R Friedman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-07       Impact factor: 2.839

Review 6.  Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research.

Authors:  Yiwei Li; Dejuan Kong; Zhiwei Wang; Fazlul H Sarkar
Journal:  Pharm Res       Date:  2010-03-20       Impact factor: 4.200

7.  Export of microRNAs and microRNA-protective protein by mammalian cells.

Authors:  Kai Wang; Shile Zhang; Jessica Weber; David Baxter; David J Galas
Journal:  Nucleic Acids Res       Date:  2010-07-07       Impact factor: 16.971

8.  Decreased expression of microRNA-21 is associated with increased cytokine production in peripheral blood mononuclear cells (PBMCs) of obese type 2 diabetic and non-diabetic subjects.

Authors:  Hossein Mazloom; Samira Alizadeh; Ensieh Nasli Esfahani; Farideh Razi; Reza Meshkani
Journal:  Mol Cell Biochem       Date:  2016-07-02       Impact factor: 3.396

9.  MicroRNA-128 regulates the differentiation of rat bone mesenchymal stem cells into neuron-like cells by Wnt signaling.

Authors:  Rui Wu; Yue Tang; Wenqiao Zang; Yuanyuan Wang; Min Li; Yuwen Du; Guoqiang Zhao; Yuming Xu
Journal:  Mol Cell Biochem       Date:  2013-12-04       Impact factor: 3.396

10.  MicroRNA-181a* Targets Nanog in a Subpopulation of CD34(+) Cells Isolated From Peripheral Blood.

Authors:  Paul J Mintz; Pål Sætrom; Vikash Reebye; Marie B Lundbæk; Kaiqin Lao; John J Rossi; Karin Ml Gaensler; Noriyuki Kasahara; Joanna P Nicholls; Steen Jensen; Abdelali Haoudi; Mohamed M Emara; Myrtle Ya Gordon; Nagy A Habib
Journal:  Mol Ther Nucleic Acids       Date:  2012-08-07       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.